《外围股市》美股期货全面升不足0.2% 道指期货升34点
亚太区股市个别发展。港股继5月份累升1.5%成功打破「五穷咒」後,今天在药明生物(02269.HK)、阿里巴巴(09988.HK)、舜宇(02382.HK)和绩後获大行维持正面评级昨天股价飙11%美团(03690.HK)依次升逾3%-6%,以及腾讯(00700.HK)升近2%支撑,午後升幅扩至288点或0.9%,报29,440;纽西兰50指数扭两连吐,回升1.2%;沪深、新加坡、南韩、台湾、泰国及越南股市升0.2%-0.7%,後者屡创纪录高。不过,日经、菲股、大马及澳洲股市反覆续软;印度孟买指数也扭四连升反覆回软。
美股期货全面靠稳,道指期货报34,547,续升34点或0.1%;标普五百期货报4,206,续升4点或0.1%;纳指一百期货现造13,706,续升20点或0.15%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.